Visitors Now:
Total Visits:
Total Stories:
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Apricus Biosciences raises US$4.6mln through share issue

Friday, September 23, 2016 8:38
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Apricus Biosciences, Inc (NASDAQ:APRI) has raised US$4.6mln through a placing with institutional shareholders at US$0.35.

The issue comes with a warrant  exercisable at US$0.45 per share with the money earmarked for general working capital.

San Diego-based, Apricus’s key product is erectile disfunction cream Vitaros, which is being steadily rolled out in Europe.

Earlier this month, Slovakia and the Czech Republic became the two latest European countries where the product went on sale.

The group intends to re-file its application for the US later this year after the Food and Drug Administration raised safety and manufacturing in the original Vitaros submission.

Shares eased 14% to 0.342.


Story by ProactiveInvestors

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.